Hostname: page-component-7c8c6479df-5xszh Total loading time: 0 Render date: 2024-03-19T07:37:40.471Z Has data issue: false hasContentIssue false

Letter to the Editor: Response to correspondence concerning ‘Recovery from chronic fatigue syndrome after treatments in the PACE trial’

Published online by Cambridge University Press:  19 July 2013

P. D. WHITE*
Affiliation:
Wolfson Institute of Preventive Medicine, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, UK
K. GOLDSMITH
Affiliation:
Biostatistics Department, Institute of Psychiatry, King's College London, UK
A. L. JOHNSON
Affiliation:
MRC Biostatistics Unit, Institute of Public Health, University of Cambridge, UK MRC Clinical Trials Unit, London, UK
T. CHALDER
Affiliation:
Academic Department of Psychological Medicine, King's College London, UK
M. SHARPE
Affiliation:
Department of Psychiatry, University of Oxford, UK
Rights & Permissions [Opens in a new window]

Abstract

Type
Correspondence
Copyright
Copyright © Cambridge University Press 2013 

The definition of recovery from any chronic illness is challenging. We therefore agree with Cox (Reference Cox2013) and Courtney (Reference Courtney2013) that no single threshold measurement is sufficient; this is why we measured several domains of improvement and combined them into a composite measure of recovery (White et al. Reference White, Goldsmith, Johnson, Chalder and Sharpe2013). Shepherd (Reference Shepherd2013) suggests asking patients whether they recovered as a result of [our italics] receiving a treatment; we did not ask this since it is not possible for individuals to ascribe change to one particular source in exclusion from all others, such as regression to the mean or external factors. Maryhew (Reference Maryhew2013) suggests self-ratings may be biased when participants cannot be masked to treatment allocation; this may be true, but is inconsistent with cognitive behaviour therapy (CBT) being more effective than adaptive pacing therapy (APT) when treatment expectations were significantly lower before treatment (White et al. Reference White, Goldsmith, Johnson, Potts, Walwyn, DeCesare, Baber, Burgess, Clark, Cox, Bavinton, Angus, Murphy, Murphy, O'Dowd, Wilks, McCrone, Chalder and Sharpe2011).

We dispute that in the PACE trial the six-minute walking test offered a better and more ‘objective’ measure of recovery, as suggested by Agardy (Reference Agardy2013), Maryhew (Reference Maryhew2013), and Shepherd (Reference Shepherd2013). First, recovery from chronic fatigue syndrome (CFS), which is defined by a patient's reported symptoms, is arguably best measured by multiple patient-reported outcome measures, rather than a single performance test. Second, and importantly, there were practical limitations to our conduct of the walking test. Due to concerns about patients with CFS coping with physical exertion, no encouragement was given to participants as they performed the test, by contrast to the way this test is usually applied (Guyatt et al. Reference Guyatt, Pugsley, Sullivan, Thompson, Berman, Jones, Fallen and Taylor1984; American Thoracic Society, 2002). Rather than encouragement, we told participants, ‘You should walk continuously if possible, but can slow down or stop if you need to.’ Furthermore we had only 10 metres of walking corridor space available, rather than the 30–50 metres of space used in other studies; this meant that participants had to stop and turn around more frequently (Guyatt et al. Reference Guyatt, Pugsley, Sullivan, Thompson, Berman, Jones, Fallen and Taylor1984; Troosters et al. Reference Troosters, Gosselink and Decramer1999; American Thoracic Society, 2002), slowing them down and thereby vitiating comparison with other studies. Finally, we had follow-up data on 72% of participants for this test, which was less than for the self-report measures (White et al. Reference White, Goldsmith, Johnson, Potts, Walwyn, DeCesare, Baber, Burgess, Clark, Cox, Bavinton, Angus, Murphy, Murphy, O'Dowd, Wilks, McCrone, Chalder and Sharpe2011).

Economic data, such as sickness benefits and employment status, have already been published by McCrone et al. (Reference McCrone, Sharpe, Chalder, Knapp, Johnson, Goldsmith and White2012). However, recovery from illness is a health status, not an economic one, and plenty of working people are unwell (Oortwijn et al. Reference Oortwijn, Nelissen, Adamini, van den Heuvel, Geuskens and Burdof2011), while well people do not necessarily work. Some of our participants were either past the age of retirement or were not in paid employment when they fell ill. In addition, follow-up at 6 months after the end of therapy may be too short a period to affect either benefits or employment. We therefore disagree with Shepherd (Reference Shepherd2013) that such outcomes constitute a useful component of recovery in the PACE trial.

We agree with Carter (Reference Carter2013) that there is a difference between sustained recovery and temporary remission; this is why we were careful to give a precise definition of recovery and to emphasize that it applied at one particular point only and to the current episode of illness (White et al. Reference White, Goldsmith, Johnson, Chalder and Sharpe2013).

Despite the complexities of measuring recovery, we believe that our approach of using multiple self-report measures provides a reasonable approach to inform clinicians' and patients' choice between available treatments. The findings from the PACE trial are clear; however we measured recovery, CBT and graded exercise therapy (GET) were more likely to lead to recovery, when added to specialist medical care (SMC), compared to either adding APT or SMC alone. Recovery after SMC alone, using our composite criteria, was only 7% – the same as that without treatment (Cairns & Hotopf, Reference Cairns and Hotopf2005) – whereas three times as many (22%) recovered after receiving CBT or GET. The PACE trial has shown that both CBT and GET are moderately effective, safe, cost-effective, and are more likely to lead to recovery (White et al. Reference White, Goldsmith, Johnson, Potts, Walwyn, DeCesare, Baber, Burgess, Clark, Cox, Bavinton, Angus, Murphy, Murphy, O'Dowd, Wilks, McCrone, Chalder and Sharpe2011, Reference White, Goldsmith, Johnson, Chalder and Sharpe2013; McCrone et al. Reference McCrone, Sharpe, Chalder, Knapp, Johnson, Goldsmith and White2012). These treatments should now be routinely offered to all those who may benefit from them (Crawley et al. Reference Crawley, Collin, White, Rimes, Sterne and May2013).

Declaration of Interest

Declaration of Interest is as stated in White et al. (Reference White, Goldsmith, Johnson, Chalder and Sharpe2013).

References

Agardy, S (2013). Comments on ‘Recovery from chronic fatigue syndrome after treatments given in the PACE trial’ [Letter]. Psychological Medicine. doi:10.1017/S003329171300113X.CrossRefGoogle ScholarPubMed
American Thoracic Society (2002). ATS Statement: Guidelines for the six-minute walk test. American Journal of Respiratory and Critical Care Medicine 166, 111117.CrossRefGoogle Scholar
Cairns, R, Hotopf, M (2005). A systematic review describing the prognosis of chronic fatigue syndrome. Occupational Medicine 55, 2031.CrossRefGoogle ScholarPubMed
Carter, S (2013). ‘Recovery from chronic fatigue syndrome after treatments given in the PACE trial’: recovery or remission? [Letter]. Psychological Medicine. doi:10.1017/S0033291713001268.CrossRefGoogle ScholarPubMed
Courtney, R (2013). ‘Recovery from chronic fatigue syndrome after treatments given in the PACE trial’: an appropriate threshold for a recovery? [Letter]. Psychological Medicine. doi:10.1017/S003329171300127X.CrossRefGoogle ScholarPubMed
Cox, D (2013). ‘Recovery from chronic fatigue syndrome after treatments given in the PACE trial’: data on the recovery groups as a whole would be useful [Letter]. Psychological Medicine. doi:10.1017/S0033291713001281.CrossRefGoogle ScholarPubMed
Crawley, E, Collin, SM, White, PD, Rimes, K, Sterne, JAC, May, MT (2013). Treatment outcome in adults with chronic fatigue syndrome: a prospective study in England based on the CFS/ME National Outcomes Database. Quarterly Journal of Medicine 28 March. doi:10.1093/qjmed/hct061.CrossRefGoogle ScholarPubMed
Guyatt, GH, Pugsley, SO, Sullivan, MJ, Thompson, PJ, Berman, LB, Jones, NL, Fallen, EL, Taylor, DW (1984). Effect of encouragement on walking test performance. Thorax 39, 818822.CrossRefGoogle ScholarPubMed
Maryhew, C (2013). Comments on ‘Recovery from chronic fatigue syndrome after treatments given in the PACE trial’ [Letter]. Psychological Medicine. doi:10.1017/S0033291713001293.CrossRefGoogle ScholarPubMed
McCrone, P, Sharpe, M, Chalder, T, Knapp, M, Johnson, AL, Goldsmith, KA, White, PD (2012). Adaptive pacing, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome: a cost-effectiveness analysis. PLoS ONE 7, e40808.CrossRefGoogle ScholarPubMed
Oortwijn, W, Nelissen, E, Adamini, S, van den Heuvel, S, Geuskens, G, Burdof, L (2011). Social determinants state of the art reviews – Health of People of Working Age – Summary Report. European Commission Directorate General for Health and Consumers. Luxembourg.Google Scholar
Shepherd, C (2013). Comments on ‘Recovery from chronic fatigue syndrome after treatments given in the PACE trial’ [Letter]. Psychological Medicine. doi:10.1017/S003329171300130X.CrossRefGoogle ScholarPubMed
Troosters, T, Gosselink, R, Decramer, M (1999). Six minute walking distance in healthy elderly subjects. European Respiratory Journal 14, 270274.CrossRefGoogle ScholarPubMed
White, PD, Goldsmith, KA, Johnson, AL, Potts, L, Walwyn, R, DeCesare, JC, Baber, HL, Burgess, M, Clark, LV, Cox, DL, Bavinton, J, Angus, BJ, Murphy, G, Murphy, M, O'Dowd, H, Wilks, D, McCrone, P, Chalder, T, Sharpe, M (2011). Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet 377, 823836.CrossRefGoogle Scholar
White, PD, Goldsmith, K, Johnson, AL, Chalder, T, Sharpe, M; PACE Trial Management Group (2013). Recovery from chronic fatigue syndrome after treatments given in the PACE trial. Psychological Medicine. Published online: 31 January 2013. doi:10.1017/S0033291713000020.Google ScholarPubMed